advertisement
11.16 Vehicles, delivery systems, pharmacokinetics, formulation (132)
Showing records 1 to 25
Search within classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation70278 Preservative-free bimatoprost 0.03% in patients with primary open-angle glaucoma or ocular hypertension in clinical practice
Pillunat LE
Clinical Ophthalmology 2016; 10: 1759-1765
70467 Efficacy and tolerability of benzalkonium chloride-free travoprost in glaucoma patients switched from benzalkonium chloride-preserved latanoprost or bimatoprost
García-Feijoo J
Clinical Ophthalmology 2016; 10: 2085-2091
70194 Long-Term Subconjunctival Delivery of Brimonidine Tartrate for Glaucoma Treatment Using a Microspheres/Carrier System
Pek YS
Advanced healthcare materials 2016; 5: 2823-2831
70135 Latanoprost-Eluting Contact Lenses in Glaucomatous Monkeys
Ciolino JB
Ophthalmology 2016; 123: 2085-2092
70071 Squeeze Me if You Can: Variability in Force Requirements to Extract a Drop From Common Glaucoma Bottles
Moore DB
Journal of Glaucoma 2016; 25: 780-784
70828 Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 6-Month Results from a Phase I/II Clinical Trial
Lewis RA
American Journal of Ophthalmology 2017; 175: 137-147
70528 Sustained Delivery of Timolol Maleate for Over 90 Days by Subconjunctival Injection
Lavik E
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 642-649
69991 Novel Polymeric Nanoparticles Intended for Ophthalmic Administration of Acetazolamide
Quinteros DA
Journal of Pharmaceutical Sciences 2016; 105: 3183-3190
70532 Nanoparticle Modified Drug Loaded Biodegradable Polymeric Contact Lenses For Sustainable Ocular Drug Delivery
Dhesingh RS
Current Drug Delivery 2016; 0:
69937 Association Between Corneal Endothelial Cell Density and Topical Glaucoma Medication Use in an Eye Bank Donor Population
Kwon JW
Cornea 2016; 0:
70780 A novel nanoparticles impregnated ocular insert for enhanced bioavailability to posterior segment of eye: In vitro, in vivo and stability studies
Rathod LV
Materials science & engineering. C, Materials for biological applications 2017; 71: 529-540
70581 Ocular Surface Evaluation in Patients Treated with Prostaglandin Analogues Considering Preservative Agent
Mlčáková E
Česka a Slovenska Oftalmologie 2016; 72: 120-127
70269 Extended wear therapeutic contact lens fabricated from timolol imprinted carboxymethyl chitosan-g-hydroxy ethyl methacrylate-g-poly acrylamide as a onetime medication for glaucoma
Anirudhan TS
European Journal of Pharmaceutics and Biopharmaceutics 2016; 109: 61-71
70355 Pharmacodynamic profile of mydriatic agents delivered by ocular piezo-ejection microdosing compared with conventional eyedropper
Ianchulev T
Therapeutic delivery 2016; 7: 751-760
70794 Bottle Characteristics of Topical International Glaucoma Medications versus Local Brands in Saudi Arabia
Al-Jumaian N
Middle East African Journal of Ophthalmology 2016; 23: 296-301
70097 Natural Compounds and Neuroprotection: Mechanisms of Action and Novel Delivery Systems
Bagli E
In vivo (Athens, Greece) 2016; 30: 535-547
70392 Sustained drug delivery for glaucoma: current data and future trends
Aref AA
Current Opinions in Ophthalmology 2017; 28: 169-174
70100 Unpreserved latanoprost in the treatment of open-angle glaucoma and ocular hypertension. A multicenter, randomized, controlled study
Denis P
Journal Français d'Ophtalmologie 2016; 39: 622-630
70827 Aids for Eye Drop Administration
Davies I
Survey of Ophthalmology 2016; 0:
70011 Evaluation of Physical Properties of Generic and Branded Travoprost Formulations
Wadhwani M
Journal of Current Glaucoma Practice 2016; 10: 49-55
70283 Ocular Drug Delivery through pHEMA-Hydrogel Contact Lenses Co-Loaded with Lipophilic Vitamins
Lee D
Scientific reports 2016; 6: 34194
70243 Drug-Loaded Nanoparticles Embedded in a Biomembrane Provide a Dual-Release Mechanism for Drug Delivery to the Eye
Sharma M
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 565-573
70665 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monothe
Konstas AG
Advances in Therapy 2017; 34: 221-235
70273 Tear Lipid Layer Thickness Change and Topical Anti-Glaucoma Medication Use
Lee SY
Optometry and Vision Science 2016; 93: 1210-1217
70097 Natural Compounds and Neuroprotection: Mechanisms of Action and Novel Delivery Systems
Goussia A
In vivo (Athens, Greece) 2016; 30: 535-547